IRYNA KINZER: Open Payments
NPI 1003380593 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,479 in 129 payments from 15 companies in 2025. Trend: 2023 $1,368 · 2024 $2,587 · 2025 $2,479
Food & beverage: $2,379Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $513 |
| UCB, Inc. | 17 | $323 |
| GENZYME CORPORATION | 11 | $276 |
| Janssen Biotech, Inc. | 13 | $275 |
| Amgen Inc. | 18 | $217 |
| Novartis Pharmaceuticals Corporation | 10 | $179 |
| Arcutis Biotherapeutics, Inc. | 9 | $156 |
| Organon LLC | 6 | $97 |
| Lilly USA, LLC | 4 | $95 |
| LEO Pharma Inc. | 4 | $91 |
Products named: SKYRIZI, Bimzelx, DUPIXENT, TREMFYA, OTEZLA, Zoryve, COSENTYX, VTAMA.
Industry payments across CA — which companies pay providers there.
